Curtis R Chong

Title: Curtis R Chong: Innovator in Angiogenesis Inhibition

Introduction

Curtis R Chong is a notable inventor based in Honolulu, HI (US). He has made significant contributions to the field of angiogenesis research, holding a total of 5 patents. His work focuses on developing methods to inhibit angiogenesis, which is crucial for treating various diseases and disorders.

Latest Patents

Among his latest patents, one describes methods of inhibiting angiogenesis and treating or preventing diseases associated with this process. This patent outlines the administration of anti-angiogenesis compounds to a subject. Another significant patent involves chirally pure isomers of itraconazole, which are also used as angiogenesis inhibitors. This innovation further emphasizes the potential of anti-angiogenesis compounds in medical treatments.

Career Highlights

Curtis R Chong is affiliated with The Johns Hopkins University, where he continues to advance his research and innovations. His work has garnered attention in the scientific community, contributing to the understanding and treatment of diseases related to angiogenesis.

Collaborations

Some of his notable coworkers include Jun O Liu and Shridhar Bhat, who collaborate with him on various research projects.

Conclusion

Curtis R Chong's contributions to angiogenesis research and his innovative patents highlight his role as a leading inventor in this critical field. His work continues to pave the way for advancements in medical treatments related to angiogenesis.